Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001415889-24-002613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-05 | 2024-02-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | S - Sale+OE | $73.87 | -1,667 | 22.2K | -7% | -$123.1K |
| D | 2024-02-05 | 2024-02-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $21.41 | +1,667 | 22.4K | +8% | +$35.7K |
| D | 2024-02-05 | 2024-02-01 | PCVX | Eydelman Mikhail | SVP, GEN COUNSEL, CORP SEC | M - OptEx | $0.00 | -1,667 | 191.7K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | S | D | 474 | $75.39 | 20,710 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $75.01 to $75.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-02-01 | S | D | 343 | $74.11 | 21,184 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $73.70 to $74.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 638 | $73.17 | 21,527 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $72.695 to $73.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-02-01 | M | A | 1,667 | $21.41 | 22,377 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-01 | S | D | 212 | $72.22 | 22,165 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $71.69 to $72.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-02-01 | M | D | 1,667 | $0.00 | 191,666 | D | $21.41 · — to 2032-05-08 | 1,667 Common Stock | (F6) 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |